Randy Milby - 18 Apr 2022 Form 4 Insider Report for Hillstream BioPharma Inc. (THAR)

Role
Chief Executive Officer, Director
Signature
/s/ Randy Milby
Issuer symbol
THAR
Transactions as of
18 Apr 2022
Net transactions value
+$24,342
Form type
4
Filing time
19 Apr 2022, 08:05:22 UTC
Previous filing
20 Jan 2022
Next filing
19 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HILS Common Stock Exercise of in-the-money or at-the-money derivative security $2,379 +7,575 +0.28% $0.3140 2,701,588 18 Apr 2022 Direct
transaction HILS Common Stock Exercise of in-the-money or at-the-money derivative security $2,379 +7,575 +0.28% $0.3140 2,709,163 18 Apr 2022 Direct
transaction HILS Common Stock Exercise of in-the-money or at-the-money derivative security $14,962 +189,393 +7% $0.0790* 2,898,556 18 Apr 2022 Direct
transaction HILS Common Stock Exercise of in-the-money or at-the-money derivative security $2,244 +28,408 +0.98% $0.0790* 2,926,964 18 Apr 2022 Direct
transaction HILS Common Stock Exercise of in-the-money or at-the-money derivative security $2,379 +7,575 +0.26% $0.3140 2,934,539 18 Apr 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HILS Options (right to purchase) Exercise of in-the-money or at-the-money derivative security $0 -7,575 -100% $0.000000* 0 18 Apr 2022 Common stock 7,575 $0.3140 Direct
transaction HILS Options (right to purchase) Exercise of in-the-money or at-the-money derivative security $0 -7,575 -100% $0.000000* 0 18 Apr 2022 Common stock 7,575 $0.3140 Direct
transaction HILS Options (right to purchase) Exercise of in-the-money or at-the-money derivative security $0 -189,393 -100% $0.000000* 0 18 Apr 2022 Common stock 189,393 $0.0790 Direct F1
transaction HILS Options (right to purchase) Exercise of in-the-money or at-the-money derivative security $0 -28,408 -75% $0.000000 9,470 18 Apr 2022 Common stock 28,408 $0.0790 Direct F2
transaction HILS Options (right to purchase) Exercise of in-the-money or at-the-money derivative security $0 -7,575 -100% $0.000000* 0 18 Apr 2022 Common stock 7,575 $0.3140 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Registrant issued the Reporting Person the options on August 30, 2019. The options vested on the date of grant and became exercisable upon completion of the Registrant's initial public offering.
F2 The Registrant issued the Reporting Person the options on July 31, 2019. The options vest as follows: (i) 9,469 options vested and became exercisable on July 31, 2020 and (ii) the balance of the options shall vest and become exercisable in 48 equal monthly installments such that the options shall vest in full by the 4th anniversary of the initial issuance date.